Prevalence and Implications of a β-Amyloid–Negative, Tau-Positive CSF Biomarker Profile in AD

This cohort study assesses the memory clinic prevalence and prognosis of individuals with a β-amyloid–negative, tau-positive cerebrospinal fluid biomarker profile.
Source: JAMA Neurology - Category: Neurology Source Type: research
More News: Brain | Neurology | Study